Cart
sales@molnova.com
PAT-1251
CAS No. 2007885-39-2
PAT-1251( PAT 1251 | PAT1251 )
Catalog No. M13132 CAS No. 2007885-39-2
PAT-1251 (PAT 1251, PAT1251) is a?potent, selective and orally bioavailable lysyl oxidase-like 2 (LOXL2) inhibitor with IC50 of 0.71 uM in human whole blood assays.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 447 | In Stock |
|
| 10MG | 651 | In Stock |
|
| 25MG | 1017 | In Stock |
|
| 50MG | 1368 | In Stock |
|
| 100MG | 1782 | In Stock |
|
| 500MG | 3573 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NamePAT-1251
-
NoteResearch use only, not for human use.
-
Brief DescriptionPAT-1251 (PAT 1251, PAT1251) is a?potent, selective and orally bioavailable lysyl oxidase-like 2 (LOXL2) inhibitor with IC50 of 0.71 uM in human whole blood assays.
-
DescriptionPAT-1251 (PAT 1251, PAT1251) is a?potent, selective and orally bioavailable lysyl oxidase-like 2 (LOXL2) inhibitor with IC50 of 0.71 uM in human whole blood assays, with high selectivity over LOX (400-fold) and other amine oxidases; exhibits efficacy in mouse bleomycin lung fibrosis model.Fibrosis Phase 1 Clinical.
-
In VitroPAT-1251 is a Lysyl Oxidase-Like 2 (LOXL2) inhibitor, with IC50s of 0.71 and 1.17 μM for hLOXL2 and hLOXL3, respectively, and also potently inhibits mouse, rat, and dog LOXL2 (IC50s, 0.10, 0.12, and 0.16 μM, respectively). PAT-1251 shows highly selective for LOXL2 over other key members of the amine oxidase family, such as the copper-dependent amine oxidases semicarbazide-sensitive amine oxidase (SSAO) and diamine oxidase (DAO), in addition to the flavin-dependent monoamine oxidases A (MAO-A) and B (MAO-B), with <10% inhibition at 10 μM.
-
In Vivo——
-
SynonymsPAT 1251 | PAT1251
-
PathwayOthers
-
TargetOther Targets
-
RecptorOther Targets
-
Research AreaOther Indications
-
IndicationFibrosis
Chemical Information
-
CAS Number2007885-39-2
-
Formula Weight399.346
-
Molecular FormulaC18H17F4N3O3
-
Purity>98% (HPLC)
-
SolubilityDMSO : ≥ 130 mg/mL 325.54 mM
-
SMILESO=C(C1=CC=CC(OC2=NC(C(F)(F)F)=CC(CN)=C2)=C1)N3C[C@@H](F)[C@H](O)C3
-
Chemical Name(3-((4-(aminomethyl)-6-(trifluoromethyl)pyridin-2-yl)oxy)phenyl)((3R,4R)-3-fluoro-4-hydroxypyrrolidin-1-yl)methanone
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Rowbottom MW, et al. J Med Chem. 2017 May 25;60(10):4403-4423.
molnova catalog
related products
-
α-(difluoromethyl)-D...
α-(difluoromethyl)-DL-Arginine (RMI 71897) is an enzyma-activated, irreversible inhibitor of arginine decarboxylase for E. coli (Ki = 800 μM), Pseudomonas aeruginosa, and Klebsiella pneumoniae.
-
beta-L-D4A
beta-L-D4A, a nucleoside HIV-1 reverse transcriptase inhibitor, exhibits biological activity by terminating DNA chain synthesis in the 5'-3' direction.
-
Epitinib succinate
Epitinib succinate is an orally active and selective epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) designed for optimal brain penetration. Epitinib succinate can be used for the research of cancer.
